期刊文献+

携带新的突变的PBP2编码基因的泛耐药鲍曼不动杆菌的发现 被引量:2

Discovery of pandrug resistant Acinetobacter baumannii carrying new mutations in the PBP2 encoding gene
下载PDF
导出
摘要 目的探讨临床分离的泛耐药鲍曼不动杆菌(pandrug resistant Acinetobacter baumannii,PDR-ABA)的青霉素结合蛋白2(penicillin-binding protein 2,PBP2)编码基因的突变状况,为临床抗生素的使用提供指导。方法我们收集了PDR-ABA并对其中的3株PDR-ABA菌进行了PBP2编码基因的全长序列测定,使用工具软件对其进行读序并与GenBank已登录的其它鲍曼不动杆菌菌株PBP2编码基因序列进行对比。结果 3株PDR-ABA之PBP2编码基因序列与鲍曼不动杆菌抗生素敏感株(SDF株)序列不同,且与GenBank已登录的其它鲍曼不动杆菌菌株PBP2编码基因序列也均不相同。结论 3株PDR-ABA耐全部β-内酰胺类药物原因可能与其PBP2编码基因的突变亦相关。 Objective To evaluate penicillin-binding protein 2(PBP2) encoding gene mutation status of pandrug resistant Acinetobacter baumannii (PDR-ABA) clinical isolates and provide guidance for the clinical use of antibiotics. Methods We collected PDR-ABA and determined full-length sequence of their PBP2 encoding gene, then we used software tools to read the sequence and compared with other Acinetobacter baumannii from GenBank. Results The sequence of PBP2 encoding gene of the 3 PDR-ABA strains is different from Acinetobacter baumannii antibiotic- sensitive strain (SDF strain), and is different from other PBP2 encoding gene ofAcinetobacter baumannii from GenBank. Conclusion The 3 PDR-ABA strains resistance to all β-1actams may be due to its PBP2 encoding gene mutations.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2014年第2期137-140,共4页 Chinese Journal of Antibiotics
关键词 泛耐药鲍曼不动杆菌 青霉素结合蛋白 耐药机制 Pandrug resistant Acinetobacter baumannii Penicillin-binding protein Resistance mechanism
  • 相关文献

参考文献12

  • 1Munoz-Price L S,Weinstein R A. Acinetobacter infection[J].{H}New England Journal of Medicine,2008,(12):1271-1281.
  • 2Cay(o) R,Rodriguez M C,Espinal P. Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii[J].{H}Antimicrobial Agents and Chemotherapy,2011,(12):5907-5913.
  • 3Papp-Wallace K M,Senkfor B,Gatta J. Early insights into the interactions of different β-lactam antibiotics and β3-1actamase inhibitors against soluble forms of Acinetobacter baumannii PBPla and Acinetobacter sp.PBP3[J].{H}Antimicrobial Agents and Chemotherapy,2012,(11):5687-5692.
  • 4Vashist J,Tiwari V. Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii[J].{H}Indian Journal of Medical Research,2011,(3):332-338.
  • 5Wilke M S,Lovering A L,Strynadka N C. Beta-lactam antibiotic resistance:a current structural perspective[J].{H}Current Opinion in Biotechnology,2005,(5):525-533.
  • 6褚少朋,汪桂华,景蓉蓉,王建新,鞠少卿.一组泛耐药鲍曼不动杆菌中发现拓普异构酶Ⅳ编码基因新的变异型[J].中华微生物学和免疫学杂志,2012,32(2):157-160. 被引量:9
  • 7翁幸鐾,糜祖煌.泛耐药鲍曼不动杆菌PBP1A、CarO及β-内酰胺酶的编码基因分析[J].中华临床感染病杂志,2012,5(4):215-220. 被引量:19
  • 8王辉,倪语星,陈民钧,胡必杰,王明贵,陈佰义,胡继红,胡云建.新型甘氨酰环素类抗菌药物替加环素的体外药敏试验操作规程[J].中华检验医学杂志,2009,32(11):1208-1213. 被引量:65
  • 9Sauvage E,Kerff F,Terrak K. The penicillin-binding proteins:structure and role in peptidoglycan biosynthesis[J].FEMSMicrobiol Rev,2008,(2):234-258.
  • 10Obara M,Nakae T. Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus[J].{H}Journal of Antimicrobial Chemotherapy,1991,(6):791-800.

二级参考文献47

  • 1王明贵.喹诺酮类抗菌药的耐药性及质粒介导耐药机制[J].中华医学杂志,2006,86(9):645-647. 被引量:35
  • 2王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 3Petersen PJ, Jacobus NV, Weiss WJ, et al. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother, 1999, 43:738-744.
  • 4Bradford P. Tigecycline: a first in class glycylcycline. Clin Micro Newsl, 2004,26:163-168.
  • 5Felmingham D. Tigecycline-the first glycylcycline to undergo clinical development: an overview of in vitro activity compared to tetracycline. J Chemother, 2005,17 Suppl 1:5-11.
  • 6Chopra I, Hawkey PM, Hinton M. Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother,1992 ,29 :245-277.
  • 7Schnappinger D, Hillen W. Tetraeyclines: antibiotic action, uptake, and resistance mechanisms. Arch Mierobiol, 1996, 165:359-369.
  • 8Bauer G, Berens C, Projan SJ, et al. Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drugdirected Fe^2 + cleavage of 16S rRNA. J Antimicrob Chemother, 2004, 53:592-599.
  • 9Olson MW, Ruzin A, Feyfant E, et al. Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother, 2006,50 : 2156 -2166.
  • 10Keeney D, Ruzin A, Bradford PA. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Mierob Drug Resist, 2007,13:1-6.

共引文献90

同被引文献64

  • 1李蓉,李文林,石小玉,梁朝,赵林,廖晚珍,徐小文,崔伟光.产ESBLs鲍曼不动杆菌的耐药特性、质粒谱及耐药基因型[J].中国抗生素杂志,2006,31(4):202-205. 被引量:25
  • 2蔡朝阳,马筱玲.青霉素结合蛋白与金黄色葡萄球菌耐药性关系研究[J].国际检验医学杂志,2006,27(4):361-363. 被引量:5
  • 3Park YK, Peck KR, Cheong HS, et al. Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea[ J ]. Emerg Infect Dis, 2009,15 ( 8 ) : 1325-1327. DOI .. 10. 3201/eid1508. 080772.
  • 4Corvec S, Caroff N, Espaze E, et al. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains [ J 1. J Antimicrob Chemother, 2003, 52 (4) .. 629-635. DOI: 10. 1093/jac/dkg407.
  • 5Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens [ J ]. Int J Med Microbiol, 2010, 300 (6) : 371-379. DOI: 10. 1016/j. ijmm. 2010.04.005.
  • 6Safari M, Mozaffari Nejad AS, Bahador A, et al. Prevalence of ESBL and MBL encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units(ICU) [ J]. Saudi J Biol Sci,2015,22(4) :424-429. DOI: 10. 1016/j. sjbs. 2015.01. 004.
  • 7Opazo A, Dorr6nguez M, Bello H, et al. OXA-type carbapene- mases in Acinetobacter baumannii in South America [ J ]. J Infect Dev Ctries, 2012,6 ( 4 ) : 311-316. DOI: 10. 3855/jidc. 2310.
  • 8Zhou H, Pi BR, Yang Q, et al. Dissemination of imipenem-re- sistant Acinetobacter baumannii strains carrying the ISAbal blaOXA-23 genes in a Chinese hospital [ J 1. J Meal Microbiol, 2007,56 ( Pt 8 ) : 1076-1080. DOI : 10. 1099/jmm. 0. 4720643.
  • 9Abbott I, Cerqueira GM, Bhuiyan S, et al. Carbapenem resist-ance in Acinetobacter baumannii: laboratory challenges, mecha- nistic insights and therapeutic strategies E J 1. Expert Rev Anti Infect Ther,2013,11 (4) :395-409. DOI:10. 1586/eri. 13.21.
  • 10Fonseca EL, Scheidegger E, Freitas FS, et al. Carbapenem-re- sistant Acinetobacter baumannii from Brazil: role of carO alleles expression and blaOXA-23 gene[ J~. BMC Microbiol,2013,13 : 245. DOI:10. 1186/1471-2180-13-245.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部